Latest Insider Transactions at Illumina, Inc. (ILMN)
This section provides a real-time view of insider transactions for Illumina, Inc. (ILMN). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of ILLUMINA, INC. to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of ILLUMINA, INC.'s insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Feb 21
2023
|
Kevin Carl Pegels Chief of Global Operations |
SELL
Payment of exercise price or tax liability
|
Direct |
409
-5.43%
|
$82,618
$202.84 P/Share
|
|
Feb 21
2023
|
Kevin Carl Pegels Chief of Global Operations |
BUY
Exercise of conversion of derivative security
|
Direct |
1,097
+12.7%
|
-
|
|
Feb 21
2023
|
Phillip G. Febbo SVP Chief Medical Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,245
-14.69%
|
$251,490
$202.84 P/Share
|
|
Feb 21
2023
|
Phillip G. Febbo SVP Chief Medical Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
3,522
+29.36%
|
-
|
|
Feb 21
2023
|
Joydeep Goswami SVP, Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,640
-13.34%
|
$331,280
$202.84 P/Share
|
|
Feb 21
2023
|
Joydeep Goswami SVP, Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
4,696
+27.64%
|
-
|
|
Feb 21
2023
|
Charles Dadswell SVP, General Counsel |
SELL
Payment of exercise price or tax liability
|
Indirect |
1,907
-15.96%
|
$385,214
$202.84 P/Share
|
|
Feb 21
2023
|
Charles Dadswell SVP, General Counsel |
BUY
Exercise of conversion of derivative security
|
Indirect |
5,282
+30.66%
|
-
|
|
Feb 06
2023
|
Susan H Tousi SVP, Chief Commercial Officer |
SELL
Open market or private sale
|
Direct |
500
-1.29%
|
$105,500
$211.57 P/Share
|
|
Jan 09
2023
|
Aimee L Hoyt SVP, Chief People Officer |
SELL
Open market or private sale
|
Direct |
871
-23.75%
|
$178,555
$205.57 P/Share
|
|
Jan 06
2023
|
Susan H Tousi SVP, Chief Commercial Officer |
SELL
Open market or private sale
|
Direct |
500
-1.28%
|
$102,000
$204.58 P/Share
|
|
Dec 06
2022
|
Susan H Tousi SVP, Chief Commercial Officer |
SELL
Open market or private sale
|
Direct |
500
-1.26%
|
$106,000
$212.63 P/Share
|
|
Nov 08
2022
|
Alexander Aravanis SVP, Chief Technology Officer |
SELL
Open market or private sale
|
Direct |
361
-11.22%
|
$78,698
$218.0 P/Share
|
|
Nov 07
2022
|
Aimee L Hoyt SVP, Chief People Officer |
SELL
Open market or private sale
|
Direct |
1,294
-27.46%
|
$288,562
$223.65 P/Share
|
|
Nov 07
2022
|
Susan H Tousi SVP, Chief Commercial Officer |
SELL
Open market or private sale
|
Direct |
500
-1.23%
|
$111,500
$223.65 P/Share
|
|
Nov 05
2022
|
Phillip G. Febbo SVP Chief Medical Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
821
-14.22%
|
$178,157
$217.19 P/Share
|
|
Nov 05
2022
|
Joydeep Goswami SVP, Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
638
-7.76%
|
$138,446
$217.19 P/Share
|
|
Nov 05
2022
|
Aimee L Hoyt SVP, Chief People Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
640
-11.96%
|
$138,880
$217.19 P/Share
|
|
Nov 05
2022
|
Kevin Carl Pegels Chief of Global Operations |
SELL
Payment of exercise price or tax liability
|
Direct |
472
-6.83%
|
$102,424
$217.19 P/Share
|
|
Nov 05
2022
|
Kathryne Gambrell Reeves SVP, Chief Marketing Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
212
-4.82%
|
$46,004
$217.19 P/Share
|
|
Nov 05
2022
|
Susan H Tousi SVP, Chief Commercial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
721
-1.74%
|
$156,457
$217.19 P/Share
|
|
Nov 05
2022
|
Scott D Ericksen VP, Chief Accounting Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
213
-3.28%
|
$46,221
$217.19 P/Share
|
|
Nov 05
2022
|
Charles Dadswell SVP, General Counsel |
SELL
Payment of exercise price or tax liability
|
Indirect |
853
-11.46%
|
$185,101
$217.19 P/Share
|
|
Nov 05
2022
|
Alexander Aravanis SVP, Chief Technology Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
191
-5.6%
|
$41,447
$217.19 P/Share
|
|
Nov 05
2022
|
Francis A De Souza President and CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
2,591
-3.26%
|
$562,247
$217.19 P/Share
|
|
Oct 06
2022
|
Susan H Tousi SVP, Chief Commercial Officer |
SELL
Open market or private sale
|
Direct |
500
-1.2%
|
$108,000
$216.59 P/Share
|
|
Oct 05
2022
|
Kathryne Gambrell Reeves SVP, Chief Marketing Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
73
-1.63%
|
$15,914
$218.52 P/Share
|
|
Oct 05
2022
|
Joydeep Goswami SVP, Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
165
-1.97%
|
$35,970
$218.52 P/Share
|
|
Jul 07
2022
|
Alexander Aravanis SVP, Chief Technology Officer |
SELL
Open market or private sale
|
Direct |
539
-13.87%
|
$107,800
$200.0 P/Share
|
|
Jul 05
2022
|
Alexander Aravanis SVP, Chief Technology Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
285
-6.83%
|
$55,005
$193.02 P/Share
|
|
Jun 10
2022
|
Susan H Tousi SVP, Chief Commercial Officer |
SELL
Open market or private sale
|
Direct |
250
-0.59%
|
$53,500
$214.85 P/Share
|
|
May 26
2022
|
Frances Arnold Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,232
+8.63%
|
-
|
|
May 26
2022
|
Robert S Epstein Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,232
+13.86%
|
-
|
|
May 26
2022
|
Scott Gottlieb Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,232
+26.2%
|
-
|
|
May 26
2022
|
Gary S Guthart Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,232
+12.73%
|
-
|
|
May 26
2022
|
Philip W Schiller Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,232
+9.2%
|
-
|
|
May 26
2022
|
John Wendell Thompson Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,232
+10.81%
|
-
|
|
May 26
2022
|
Caroline Dorsa Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,232
+11.61%
|
-
|
|
May 26
2022
|
Susan E Siegel Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,232
+15.98%
|
-
|
|
May 25
2022
|
Caroline Dorsa Director |
SELL
Payment of exercise price or tax liability
|
Direct |
352
-4.14%
|
$85,184
$242.4 P/Share
|
|
May 25
2022
|
Susan E Siegel Director |
SELL
Payment of exercise price or tax liability
|
Direct |
352
-6.29%
|
$85,184
$242.4 P/Share
|
|
May 05
2022
|
John Edward Frank Chief Public Affairs Officer |
BUY
Grant, award, or other acquisition
|
Direct |
1,714
+50.0%
|
-
|
|
May 05
2022
|
Jose Torres VP, Chief Accounting Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
69
-3.8%
|
$20,079
$291.72 P/Share
|
|
Apr 28
2022
|
Charles Dadswell SVP, General Counsel |
SELL
Open market or private sale
|
Indirect |
368
-4.72%
|
$110,400
$300.13 P/Share
|
|
Apr 12
2022
|
Aimee L Hoyt SVP, Chief People Officer |
SELL
Open market or private sale
|
Direct |
2,474
-5.0%
|
$858,478
$347.54 P/Share
|
|
Apr 06
2022
|
Phillip G. Febbo SVP Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
1,988
-25.61%
|
$715,680
$360.01 P/Share
|
|
Apr 05
2022
|
Carissa Rollins SVP, Chief Information Officer |
BUY
Grant, award, or other acquisition
|
Direct |
1,375
+46.61%
|
-
|
|
Apr 05
2022
|
Phillip G. Febbo SVP Chief Medical Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
131
-1.66%
|
$47,553
$363.84 P/Share
|
|
Apr 05
2022
|
Kevin Carl Pegels Chief of Global Operations |
SELL
Payment of exercise price or tax liability
|
Direct |
125
-1.78%
|
$45,375
$363.84 P/Share
|
|
Mar 28
2022
|
Charles Dadswell SVP, General Counsel |
SELL
Open market or private sale
|
Indirect |
368
-4.51%
|
$125,856
$342.83 P/Share
|